Associated Papers
Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer.
Arnedos M et al.
European Journal of Cancer (oxford, England : 1990), 2012
Select a paper to view details